Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts.
Avolio
A W
AW
Surgical Department, Catholic University, Rome, Italy.
Nanni
G
G
Citterio
F
F
Pozzetto
U
U
Magalini
S C
SC
Zappacosta
B
B
Tacchino
R M
RM
Zuppi
C
C
Castagneto
M
M
D000118:Acetylglucosaminidase / Q000652:urine*; D015415:Biomarkers / Q000652:urine*; D003124:Colorimetry; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000627:therapeutic use*; D006596:Hexosaminidases / Q000652:urine*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D011863:Radioimmunoassay; D014184:Transplantation, Homologous
D015415:Biomarkers; D003524:Cyclosporins; D003404:Creatinine; D006596:Hexosaminidases; D000118:Acetylglucosaminidase